S. Paul

990 total citations · 1 hit paper
14 papers, 707 citations indexed

About

S. Paul is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, S. Paul has authored 14 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in S. Paul's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). S. Paul is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). S. Paul collaborates with scholars based in United States, Spain and India. S. Paul's co-authors include Adolfo Díez‐Pérez, Unni Syversen, S. Adámi, Eric Orwoll, Charlotte M. Boney, Philip A. Gruppuso, Fernando Barata, Frank V. Fossella, Binh Nguyen and Rolf A. Stahel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Endocrinology.

In The Last Decade

S. Paul

13 papers receiving 674 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis

2003 522 citations Eric Orwoll, S. Paul et al. Journal of Bone and Mineral Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Paul United States	8	476	459	255	102	95	14	707
Douglas W. Axelrod United States	7	465 1.0×	498 1.1×	319 1.3×	64 0.6×	68 0.7×	13	847
F. J. F. E. Vismans Netherlands	8	459 1.0×	448 1.0×	309 1.2×	43 0.4×	62 0.7×	11	709
Adrien Sipos United States	9	626 1.3×	703 1.5×	443 1.7×	16 0.2×	108 1.1×	11	920
Guillermo Alonso Spain	11	289 0.6×	134 0.3×	237 0.9×	287 2.8×	68 0.7×	39	703
M. Tellez United Kingdom	13	192 0.4×	237 0.5×	99 0.4×	40 0.4×	97 1.0×	23	513
Wim H. Scheele United States	8	524 1.1×	642 1.4×	382 1.5×	15 0.1×	128 1.3×	13	905
Ikuko Tanaka Japan	10	196 0.4×	205 0.4×	183 0.7×	24 0.2×	49 0.5×	27	594
J. Walls United Kingdom	14	310 0.7×	111 0.2×	79 0.3×	96 0.9×	82 0.9×	37	598
S. Horlait France	11	368 0.8×	542 1.2×	311 1.2×	11 0.1×	183 1.9×	13	751
Louise Rousseau Canada	12	350 0.7×	151 0.3×	167 0.7×	96 0.9×	102 1.1×	20	885

Countries citing papers authored by S. Paul

Since Specialization

Citations

This map shows the geographic impact of S. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Paul more than expected).

Fields of papers citing papers by S. Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Paul. The network helps show where S. Paul may publish in the future.

Co-authorship network of co-authors of S. Paul

This figure shows the co-authorship network connecting the top 25 collaborators of S. Paul. A scholar is included among the top collaborators of S. Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Paul. S. Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Paul, S., Lars Donath, Jessica Hoppstädter, & Anne Hecksteden. (2024). Resistance but not endurance training suppresses glucocorticoid-induced leucine zipper (GILZ) expression in human skeletal muscle. European Journal of Applied Physiology. 125(4). 1023–1036.

Paul, S., et al.. (2011). Association and treatment response to capecitabine-based chemoradiotherapy with CYP2C9 polymorphism in head and neck cancer. Indian Journal of Cancer. 48(2). 223–223. 6 indexed citations

Weiss, Glen J., Rafael Rosell, Frank V. Fossella, et al.. (2007). The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. Annals of Oncology. 18(3). 453–460. 65 indexed citations

Ghosh, Santanu, S. Paul, Nilay Kanti Das, & Tapan K. Bhattacharyya. (2007). A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis.. PubMed. 105(5). 260–2. 8 indexed citations

Nguyen, Binh, S. Paul, Katherine E. Posther, & Alan Sandler. (2006). The effect of smoking history on survival outcome: An exploratory analysis of a phase III study of gemcitabine and cisplatin in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7141–7141. 2 indexed citations

Bunn, P A, R. Rosell, Frank V. Fossella, et al.. (2005). PD-068 An exploratory analysis of a phase III study in patients with advanced non-small cell lung cancer (NSCLC): The impact of first-line gemcitabine and platinum therapy on the outcome of second-line therapy with pemetrexed or docetaxel. Lung Cancer. 49. S86–S86. 4 indexed citations

Orwoll, Eric, et al.. (2003). The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis. Journal of Bone and Mineral Research. 18(1). 9–17. 522 indexed citations breakdown →

Scagliotti, Giorgio V., C. Kortsik, C. Manegold, et al.. (2003). O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer. Lung Cancer. 41. S79–S79. 16 indexed citations

Kuller, L. H., et al.. (1998). The effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. Journal of the Society for Gynecologic Investigation. 5(1). 61A–61A. 10 indexed citations

10.

Oblon, D J, S. Paul, & Ronald A. Yankee. (1997). Allogeneic transplantation after a conditioning regimen with ifosfamide, carboplatin and etoposide (ICE). Bone Marrow Transplantation. 20(5). 421–423. 4 indexed citations

11.

Walsh, Brian W., et al.. (1997). 2.P.313 The effect of raloxifene on markers of cardiovascular risk in healthy, post-menopausal women. Atherosclerosis. 134(1-2). 182–182. 4 indexed citations

12.

Boney, Charlotte M., et al.. (1996). Regulation of preadipocyte factor-1 gene expression during 3T3-L1 cell differentiation.. Endocrinology. 137(7). 2923–2928. 37 indexed citations

13.

Fallon, Barbara G., et al.. (1991). A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors. Cancer. 68(8). 1708–1713. 10 indexed citations

14.

Lokich, J, et al.. (1983). Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy.. PubMed. 67(9). 791–3. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact